Innoveren Scientific Inc. (IVRN)
OTCMKTS
· Delayed Price · Currency is USD
0.0004
-0.0003 (-42.86%)
At close: Jan 14, 2026
Innoveren Scientific Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
Period Ending | Sep '23 Sep 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
| Net Income | -3.26 | -10.3 | -4.8 | -6.46 | -29.81 | -4.39 |
| Depreciation & Amortization | 0.01 | 0.01 | 0.02 | 0.08 | 0.83 | 0.1 |
| Other Amortization | - | - | - | 1.4 | 0.15 | - |
| Loss (Gain) From Sale of Assets | - | 0.01 | 0.09 | 0 | - | - |
| Asset Writedown & Restructuring Costs | 0.79 | 2.04 | 0.14 | - | 15.51 | 0.61 |
| Stock-Based Compensation | 0.15 | 0.59 | 1.18 | 0.04 | 1.88 | - |
| Provision & Write-off of Bad Debts | 0.03 | 0.07 | 0.01 | 0.01 | 0.09 | - |
| Other Operating Activities | 0.35 | 5.21 | -0.7 | -2.13 | -0.85 | - |
| Change in Accounts Receivable | -0.01 | -0.05 | -0.03 | 0.02 | 0.05 | 0.06 |
| Change in Accounts Payable | 0.42 | 0.36 | -0.42 | -0.48 | 0.12 | -0.1 |
| Change in Unearned Revenue | - | -0.41 | -0.22 | -0.41 | 0.72 | -0.31 |
| Change in Other Net Operating Assets | 0.6 | 0.57 | -0.09 | 0.69 | -0.99 | 0.5 |
| Operating Cash Flow | -0.92 | -1.91 | -4.81 | -7.26 | -12.29 | -3.54 |
| Capital Expenditures | - | - | -0.01 | -0 | -0.02 | -0.01 |
| Cash Acquisitions | - | 0 | - | - | -0.37 | - |
| Sale (Purchase) of Intangibles | - | - | - | - | - | -0.01 |
| Investing Cash Flow | 0.87 | 0 | -0.01 | -0 | -0.39 | -0.02 |
| Short-Term Debt Issued | - | 0.53 | 3.33 | - | 1.64 | 0.94 |
| Long-Term Debt Issued | - | - | - | 4.65 | 2.61 | 4.31 |
| Total Debt Issued | 0.65 | 0.53 | 3.33 | 4.65 | 4.25 | 5.24 |
| Short-Term Debt Repaid | - | - | - | - | - | -1.86 |
| Long-Term Debt Repaid | - | -0.12 | -0.05 | -0.01 | -0.37 | - |
| Total Debt Repaid | -0.13 | -0.12 | -0.05 | -0.01 | -0.37 | -1.86 |
| Net Debt Issued (Repaid) | 0.53 | 0.41 | 3.27 | 4.64 | 3.88 | 3.39 |
| Issuance of Common Stock | 0.03 | 1.43 | - | - | 4.34 | - |
| Dividends Paid | - | - | - | - | -0.01 | - |
| Other Financing Activities | - | -0.01 | - | - | 2.4 | - |
| Financing Cash Flow | 0.56 | 1.82 | 3.27 | 7.48 | 14.04 | 3.39 |
| Net Cash Flow | 0.51 | -0.1 | -1.55 | 0.22 | 1.35 | -0.18 |
| Free Cash Flow | -0.92 | -1.91 | -4.82 | -7.26 | -12.31 | -3.56 |
| Free Cash Flow Margin | - | -422.03% | -298.95% | -337.57% | -147.50% | -45.11% |
| Free Cash Flow Per Share | -1.55 | -6.51 | -33.06 | -65.12 | -127.76 | -105.64 |
| Cash Interest Paid | 0.08 | 0.01 | 0.01 | 0.03 | 0.2 | 0.03 |
| Levered Free Cash Flow | 0.96 | 0.67 | -2.86 | -4.22 | -5.28 | - |
| Unlevered Free Cash Flow | 1.24 | 0.9 | -2.75 | -4.7 | -5.25 | - |
| Change in Working Capital | 1.01 | 0.46 | -0.76 | -0.19 | -0.1 | 0.15 |
Source: S&P Capital IQ. Standard template. Financial Sources.